Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Earnings
  • Equities
  • General
  • Guidance
  • Markets
  • Movers
  • News

TripAdvisor Is Down Over 30% After Q1 Results – What’s Going On?

By Nabaparna Bhattacharya
May 8, 9:11 AM
TripAdvisor faces over 30% drop in shares post-Q1, despite surpassing earnings expectations, as transactions cease and tax settlements loom.

TRIP

Read More
1 minute read
  • Biotech
  • General
  • News

Tivic Health Announces Completion Of Non-Invasive VNS Study Demonstrating Effective Biological Changes In The Autonomic, Cardiac, And Central Nervous Systems

By Benzinga Newsdesk
May 8, 9:06 AM
Tivic Health® Systems, Inc. (("Tivic Health", NASDAQ:TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today the final results of their pilot research study with The

TIVC

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • News

CEL-SCI Receives FDA Approval For Its Confirmatory Study Of Multikine For The Treatment Of Head & Neck Cancer

By Benzinga Newsdesk
May 8, 9:03 AM
Critical milestone achieved—the FDA accepted CEL-SCI's selection criteria defining the Multikine target population before surgerySelected patient population had 73% survival with Multikine vs. 45% without Multikine based

CVM

Read More
2 minute read
  • Earnings
  • Equities
  • General
  • Guidance
  • Movers
  • News

Office Depot Parent ODP Boosts FY24 EPS Outlook Despite Bumpy Q1 Ride: Details

By Shivani Kumaresan
May 8, 9:01 AM
Dive into the latest earnings report of ODP Corporation. Despite a sales decline in Q1 FY24, the company saw a significant rise in gross profit. Find out the key factors influencing its financial performance and CEO Gerry Smith's insights on the challenges faced.

ODP

Read More
1 minute read
  • Biotech
  • General
  • News

PainReform CEO Ilan Hadar Discusses Latest Developments Related To PRF-110 To Help Tackle The Opioid Epidemic

By Benzinga Newsdesk
May 8, 8:39 AM
PainReform Ltd. (NASDAQ:PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that Ilan Hadar, Chief Executive

PRFX

Read More
1 minute read
  • Biotech
  • General
  • News

Neurocrine Biosciences To Begin Initiation Of Phase 1 Clinical Study Evaluating Effects Of NBI-1117567 In Healthy Adults

By Benzinga Newsdesk
May 8, 8:38 AM
Neurocrine Biosciences, Inc. (NASDAQ:NBIX), today announced the initiation of its Phase 1 first-in-human clinical study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of investigational

NBIX

Read More
2 minute read
  • General
  • News
  • Politics
  • Tech

US Mulls Over Regulations To Restrict China’s Access To Advanced AI Software Behind Apps Like ChatGPT

By Benzinga Neuro
May 8, 8:35 AM
This move is viewed as a fresh strategy to safeguard U.S. AI from China, succeeding a series of measures over the past two years aimed at blocking the export of sophisticated AI chips to the Asian country.

GOOG

Read More
2 minute read
  • Equities
  • General
  • Guidance
  • Markets
  • Movers
  • News

Reddit’s Competitive Edge Hidden In Age Demographics? CEO Says ‘Where Somebody Might Age Out Of Social Media, They Age Into Reddit’

By Nabaparna Bhattacharya
May 8, 8:33 AM
Reddit's post-IPO Q1 results reveal losses but highlight a promising trend: its unique appeal across age demographics, positioning it as a platform where users transition into with age, contributing to its soaring stock prices.

RDDT

Read More
1 minute read
  • Biotech
  • General
  • News

Acumen Pharmaceuticals Says First Patient Dosed In ALTITUDE-AD, A Phase 2 Clinical Trial Of Sabirnetug In Early Alzheimer’s Disease

By Benzinga Newsdesk
May 8, 8:28 AM
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer's disease

ABOS

Read More
1 minute read
  • Earnings
  • Equities
  • General
  • Guidance
  • Movers
  • News

LL Flooring Posts Q1 Earnings Below Estimates As Interest Rate And Inflation Bite; Dodges Outlook

By Shivani Kumaresan
May 8, 8:27 AM
Discover insights into LL Flooring Holdings, Inc.'s first-quarter FY24 performance, revealing a 21.7% sales decline to $188.490 million. Despite a 21.5% drop in comparable store sales, the gross margin expanded to 37.8%. However, adjusted EPS fell to $(1.04), missing estimates.

LL

Posts pagination

Previous 1 … 122 123 124 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service